masthead-publications

Categories

Filter by Topics

ABC-DLBCL airway remodeling AKT Targeted Therapy ALK AR-Specific T Cells asthma Autocrine Signaling AXL B-cell lymphoma biofluid biomarker Biomarker Biomarker Analysis Biomarker Discovery biomarker patient stratification Biomarker Validation Biomarkers Biomarkers Outcome Bladder cancer immune response CD44 Cells Cerebral Spinal Fluid Checkpoint Inhibitors chemoresistance chronic obstructive pulmonary disease Circulating miRNAs Classification clinical trial Clinical Trials Colon Colorectal cancer comparative approach Comparison study comprehensive gene expression study Cord blood buffy coat Core Needle Biopsy Custom mRNA detection Diabetes Diagnostic Biomarkers differential diagnosis Differential Expression differentiation Diffuse Large B-cell Lymphoma Diffuse large B-cell lymphoma DLBCL DLBDL Drug Response drug safety Drug Targets EGFR Muatations EMT EMT signals Epigenetics Epigenomic Epstein-Barr Exosomes Expression Profiling Fabry Disease Feasibility FFPE FFPE canine tumor FGF Ligand Trap Gene expression gene expression Gene Expression Analysis Gene expression profiling Gene pathway analysis Genomic Genomic bioinformatics HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBLCL Cell of Origin Assay HTG EdgeSeq DLBLCL Cell of Origin Assay EU HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq Mouse mRNA Tumor Response Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System HTG EdgeSeq System Oncology Biomarker Panel human hypoxia Immune Immune Related Genes Immuno-Oncology immunofluorescence immunology Immunotherapy induction chemotherapy Inflammation Interferon Gamma Signature juvenile arthritis liquid biopsy Lung Lung adenocarcinoma Lung cancer lymph node metastasis Lymphoma Melanoma mesothelioma metastatic colorectal Methods Comparison mice microRNA miRNA miRNA WTA Molecular Characterization Mouse Mouse mRNA mRNA mRNA custom mRNA expression in tumors mTOR pathway mTORC1 mTORC2 mucin hypersecretion Muscle mutation myocardial reperfusion NAFLD Neoantigens neuroendocrine tumor nivolumab Non-small cell lung cancer non-small cell lung cancer NSCLC Oncogenes Oncology Onomirs Oral oral cancer oral squamous cell carcinoma osteoclast Ovarian cancer P13KmTOR Inhibitor palbociclib Pancreas Pancreatic ductal adenocarcinoma Paralysis partition approach Pathway Analysis Pathways PCA Cell Lines PD-1 PD-L1 PI3K signaling pathway plasma Plasma predictive predictive biomarker Predictive Biomarkers Predictive Modeling profiling Profiling Signature Development prognostic Prognostic Prognostic Biomarkers programmed death-1 programmed death-ligand 1 progression free-survival Prostate prostate cancer qNPA regulation Response rate Reveal risk score SCBC SCLC serum Signaling Inhibitors Signaling Pathways Signature Development Signature Validation Signatures sinonasal undifferentiated carcinoma Small Cell Bladder Cancer Small cell bladder cancer Small cell lung cancer SPECS Lung Consortium Squamous cell carcinoma Sub-typing surveillance Survival Outcomes synovial fluid T cell T-cells Technology Comparison therapeutic target Therapeutic targets TMB Toxicity Treatment Outcome tumor heterogeneity tumor microenvironment Urothelial carcinoma Uveal melanoma Vistusertib WNT Path Signaling Xenograft Tissue

2020

Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Woment with Treatment-Naïve Metastatic Breast Cancer

Finn, R. S., et al. Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Woment with Treatment-Naïve Metastatic Breast Cancer. Clinical Cancer Research | Precision Medicine and Imaging. 2020 Jan 15. 26:110-21. DOI: 10.1158/1078-0432.CCR-19-0751.

Download pdf 1.4MB

MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality

Yoon, A. J., et al. MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at thigh-risk for cancer-specific mortality. Head and Neck. 2020; 1-14

Download pdf 1.7MB

2019

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Younes, A., et al. Journal of Clinical Oncology 2019 Mar22;37(15):1285-1295. Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

Download pdf 1.2MB

Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases

Lohinai, Z., et al. Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases. Translational Lung Cancer Research 2019; 8(6):938-950

Download pdf 1.3MB

Impact of short- and long-term electrically induced muscle exercise on gene signaling pathways, gene expression, and PGC1a methylation in men with spinal cord injury.

Petrie, M. A., et al. Impact of short- and long-term electrically induced muscle exercise on gene signaling pathways, gene expression, and PGC1a methylation in men with spinal cord injury. Physiology Genomics 2019 Dec 23. 52: 71-80.

Download pdf 2.7MB

Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer.

Koopman, L. A., et al. Enapotamab bedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer. Journal Clinical Investigation insight. 2019 Nov 1;4(21):e128199.

Download pdf 3.8MB

Page last updated February 21, 2020